About
Arcus Biosciences is a clinical-stage biopharmaceutical company developing small molecule and antibody therapies for cancer treatment by targeting immuno-oncology pathways and advancing combination therapies through clinical trials.
Explore Arcus Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.